26 related articles for article (PubMed ID: 38647152)
21. Cytotoxic Nitrobenzoyl Sesquiterpenoids from an Antarctica Sponge-Derived
Sun C; Liu X; Sun N; Zhang X; Shah M; Zhang G; Che Q; Zhu T; Li J; Li D
J Nat Prod; 2022 Apr; 85(4):987-996. PubMed ID: 35380848
[TBL] [Abstract][Full Text] [Related]
22. Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model.
Jabarin A; Shtar G; Feinshtein V; Mazuz E; Shapira B; Ben-Shabat S; Rokach L
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38647152
[TBL] [Abstract][Full Text] [Related]
23. Exploring the therapeutic potential of focal adhesion kinase inhibition in overcoming chemoresistance in pancreatic ductal adenocarcinoma.
Scianò F; Terrana F; Pecoraro C; Parrino B; Cascioferro S; Diana P; Giovannetti E; Carbone D
Future Med Chem; 2024 Feb; 16(3):271-289. PubMed ID: 38269431
[TBL] [Abstract][Full Text] [Related]
24. Novel agents for pancreatic ductal adenocarcinoma: emerging therapeutics and future directions.
Zhang Y; Yang C; Cheng H; Fan Z; Huang Q; Lu Y; Fan K; Luo G; Jin K; Wang Z; Liu C; Yu X
J Hematol Oncol; 2018 Jan; 11(1):14. PubMed ID: 29386069
[TBL] [Abstract][Full Text] [Related]
25. Overcoming chemoresistance by targeting reprogrammed metabolism: the Achilles' heel of pancreatic ductal adenocarcinoma.
Tuerhong A; Xu J; Shi S; Tan Z; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Liang C
Cell Mol Life Sci; 2021 Jul; 78(14):5505-5526. PubMed ID: 34131808
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
